Helsinki, Finland

Raili Paasivuo

This inventor holds 1 USPTO granted patent. Top assignee: Locus Genex Oy. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raili Paasivuo. Retrieved from https://idiyas.com/inventor/raili-paasivuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raili Paasivuo: Innovator in Reactive Condition Diagnosis

Introduction

Raili Paasivuo is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medical diagnostics, particularly in the detection of reactive conditions such as malignant tumors. His innovative approach has the potential to enhance early diagnosis and treatment options for patients.

Latest Patents

Raili Paasivuo holds a patent for a method that focuses on the diagnosis of reactive conditions. The invention involves determining the amount of cellular fibronectin in a body fluid, where an elevated amount serves as a marker for a reactive condition. This method is especially effective for diagnosing carcinomas, including colon carcinoma. He has 1 patent to his name.

Career Highlights

Paasivuo is associated with Locus Genex Oy, a company that specializes in advanced diagnostic solutions. His work at the company reflects his commitment to improving healthcare through innovative technologies. His contributions have been instrumental in developing methods that can lead to better patient outcomes.

Collaborations

Raili Paasivuo collaborates with talented professionals in his field, including Paul Partanen and Sari Ylatupa. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Raili Paasivuo's work in the diagnosis of reactive conditions exemplifies the impact of innovation in healthcare. His patented method offers promising advancements in the early detection of malignant tumors, showcasing the importance of research and collaboration in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…